Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

GlaxoSmithKline (GSK) and Merck KGaA have entered into a global strategic alliance, worth up to $4.2 billion, to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy for treating...

Pfizer has formed a manufacturing pact with Medochemie, a Limassol, Cyprus-based generics pharmaceutical and consumer healthcare company, under which Medochemie will be manufacturing select Pfizer medicines in Vietnam. The companies announced the...

AstraZeneca plans to close two biomanufacturing plants in Colorado, one in Boulder and another in Longmont, due to what the company said is part of a global restructuring to streamline its biologics production and improve the efficiency of its...

The US Food and Drug Administration (FDA) has issued draft guidance and outlined future guidances to improve the so-called Orange Book, officially known as the Approved Drug Products with Therapeutic Equivalence Evaluations Publication, which...

GlaxoSmithKline (GSK) has initiated a succession plan for a new chairman following the announcement by its current chairman, Philip Hampton, of his intention to step down as non-executive Chairman. Philip was appointed to the company’s Board of...

GlaxoSmithKline (GSK) has completed its $5.1-billion acquisition of Tesaro, an oncology-focused company based in Waltham, Massachusetts. The deal was announced in December 2018. Tesaro is a commercial-stage biopharmaceutical company, with a...

Genentech, a member of the Roche Group, has appointed Alexander Hardy, currently Head of Global Product Strategy, as chief executive officer (CEO), effective March 1, 2019. He succeeds Bill Anderson, who was recently appointed CEO, Roche...